Literature DB >> 16517585

COPD exacerbations . 2: aetiology.

E Sapey1, R A Stockley.   

Abstract

Exacerbations of COPD are thought to be caused by complex interactions between the host, bacteria, viruses, and environmental pollution. These factors increase the inflammatory burden in the lower airways, overwhelming the protective anti-inflammatory defences leading to tissue damage. Frequent exacerbations are associated with increased morbidity and mortality, a faster decline in lung function, and poorer health status, so prevention or optimal treatment of exacerbations is a global priority. In order to evolve new treatment strategies there has been great interest in the aetiology and pathophysiology of exacerbations, but progress has been hindered by the heterogeneous nature of these episodes, vague definitions of an exacerbation, and poor stratification of known confounding factors when interpreting results. We review how an exacerbation should be defined, its inflammatory basis, and the importance of exacerbations on disease progression. Important aetiologies, with their potential underlying mechanisms, are discussed and the significance of each aetiology is considered.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16517585      PMCID: PMC2080749          DOI: 10.1136/thx.2005.041822

Source DB:  PubMed          Journal:  Thorax        ISSN: 0040-6376            Impact factor:   9.139


  126 in total

1.  The role of oxidative stress in rhinovirus induced elaboration of IL-8 by respiratory epithelial cells.

Authors:  M C Biagioli; P Kaul; I Singh; R B Turner
Journal:  Free Radic Biol Med       Date:  1999-02       Impact factor: 7.376

2.  Effect of exacerbation on quality of life in patients with chronic obstructive pulmonary disease.

Authors:  T A Seemungal; G C Donaldson; E A Paul; J C Bestall; D J Jeffries; J A Wedzicha
Journal:  Am J Respir Crit Care Med       Date:  1998-05       Impact factor: 21.405

3.  Bronchial microbial patterns in severe exacerbations of chronic obstructive pulmonary disease (COPD) requiring mechanical ventilation.

Authors:  N Soler; A Torres; S Ewig; J Gonzalez; R Celis; M El-Ebiary; C Hernandez; R Rodriguez-Roisin
Journal:  Am J Respir Crit Care Med       Date:  1998-05       Impact factor: 21.405

4.  Antibacterial components in bronchoalveolar lavage fluid from healthy individuals and sarcoidosis patients.

Authors:  B Agerberth; J Grunewald; E Castaños-Velez; B Olsson; H Jörnvall; H Wigzell; A Eklund; G H Gudmundsson
Journal:  Am J Respir Crit Care Med       Date:  1999-07       Impact factor: 21.405

5.  Rhinovirus infection induces expression of its own receptor intercellular adhesion molecule 1 (ICAM-1) via increased NF-kappaB-mediated transcription.

Authors:  A Papi; S L Johnston
Journal:  J Biol Chem       Date:  1999-04-02       Impact factor: 5.157

6.  Effect of temperature on lung function and symptoms in chronic obstructive pulmonary disease.

Authors:  G C Donaldson; T Seemungal; D J Jeffries; J A Wedzicha
Journal:  Eur Respir J       Date:  1999-04       Impact factor: 16.671

Review 7.  Do bacteria cause exacerbations of COPD?

Authors:  J V Hirschmann
Journal:  Chest       Date:  2000-07       Impact factor: 9.410

8.  MEKC of desmosine and isodesmosine in urine of chronic destructive lung disease patients.

Authors:  S Viglio; P Iadarola; A Lupi; R Trisolini; C Tinelli; B Balbi; V Grassi; D Worlitzsch; G Döring; F Meloni; K C Meyer; L Dowson; S L Hill; R A Stockley; M Luisetti
Journal:  Eur Respir J       Date:  2000-06       Impact factor: 16.671

9.  Predisposing factors to bacterial colonization in chronic obstructive pulmonary disease.

Authors:  R Zalacain; V Sobradillo; J Amilibia; J Barrón; V Achótegui; J I Pijoan; J L Llorente
Journal:  Eur Respir J       Date:  1999-02       Impact factor: 16.671

10.  Airways microbial flora in COPD patients in stable clinical conditions and during exacerbations: a bronchoscopic investigation.

Authors:  R Pela; F Marchesani; C Agostinelli; D Staccioli; L Cecarini; C Bassotti; C M Sanguinetti
Journal:  Monaldi Arch Chest Dis       Date:  1998-06
View more
  135 in total

1.  Elastase/LPS-exposed mice exhibit impaired innate immune responses to bacterial challenge: role of scavenger receptor A.

Authors:  Shyamala Ganesan; Andrea N Faris; Adam T Comstock; Joanne Sonstein; Jeffrey L Curtis; Uma S Sajjan
Journal:  Am J Pathol       Date:  2011-11-08       Impact factor: 4.307

2.  RIG-like helicase innate immunity inhibits vascular endothelial growth factor tissue responses via a type I IFN-dependent mechanism.

Authors:  Bing Ma; Charles S Dela Cruz; Dominik Hartl; Min-Jong Kang; Shervin Takyar; Robert J Homer; Chun Geun Lee; Jack A Elias
Journal:  Am J Respir Crit Care Med       Date:  2011-01-28       Impact factor: 21.405

Review 3.  The influence of virus infections on the course of COPD.

Authors:  H Frickmann; S Jungblut; T O Hirche; U Groß; M Kuhns; A E Zautner
Journal:  Eur J Microbiol Immunol (Bp)       Date:  2012-09-10

4.  Escalation and De-escalation of Therapy in COPD: Myths, Realities and Perspectives.

Authors:  Mario Cazzola; Paola Rogliani; Maria Gabriella Matera
Journal:  Drugs       Date:  2015-09       Impact factor: 9.546

Review 5.  Optimizing bronchodilation in the prevention of COPD exacerbations.

Authors:  Marc Miravitlles; Antonio Anzueto; José R Jardim
Journal:  Respir Res       Date:  2017-06-20

6.  What is (and what is not) a COPD exacerbation: thoughts from the new GOLD guidelines.

Authors:  J R Hurst; J A Wedzicha
Journal:  Thorax       Date:  2007-03       Impact factor: 9.139

7.  Chronic obstructive pulmonary disease exacerbation and risk of pulmonary embolism.

Authors:  J A Wedzicha; J R Hurst
Journal:  Thorax       Date:  2007-02       Impact factor: 9.139

8.  The Anti-inflammatory Effect of Alpha-1 Antitrypsin in Rhinovirus-infected Human Airway Epithelial Cells.

Authors:  Di Jiang; Reena Berman; Qun Wu; Connor Stevenson; Hong Wei Chu
Journal:  J Clin Cell Immunol       Date:  2016-12-05

9.  A Prospective Study of Bacteriological Etiology in Hospitalized Acute Exacerbation of COPD Patients: Relationship with Lung Function and Respiratory Failure.

Authors:  Ashok Kuwal; Vinod Joshi; Naveen Dutt; Surjit Singh; Kailash Chand Agarwal; Gopal Purohit
Journal:  Turk Thorac J       Date:  2017-11-29

Review 10.  Influenza vaccination for patients with chronic obstructive pulmonary disease: understanding immunogenicity, efficacy and effectiveness.

Authors:  Farzaneh Sanei; Tom Wilkinson
Journal:  Ther Adv Respir Dis       Date:  2016-05-18       Impact factor: 4.031

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.